Shares of Watson Pharmaceutical (WPI) were upgraded by UBS on Friday from Neutral to Buy after announcing quarterly results on Thursday. . The firm changed the price target from $43 to $59. Watson had reported that net revenue grew 33% to $882.4 million, compared to $662.1 million in the third quarter 2009.On an adjusted cash basis, net income increased 18% to $105.9 million or $0.85 per share, compared to $90.0 million or $0.78 per share in the third quarter 2009.
Shares are higher by nearly 1.3 percent.
American Express (NYSE:AXP) was upgraded by Argus from Hold to Buy with a price target of $50, following the announcement of the acquisition of Accertify for $150 million.
Shares are higher by about six tenths of a percent.
Goodrich Petroleum (GDP) was upgraded by Stifel Nicolaus from Hold to Buy, with a price target of $17. The upgrade was based on emerging potential for the company's Eagle Ford Shale and Shelby Trough properties.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.